In Vivo Evaluation of TNF-Alpha in the Lungs of Patients Affected by Sarcoidosis

Figure 2

-Infliximab scintigraphy of a sarcoidosis patient (patient 4/F) acquired at 6 h (anterior and posterior views (a)) and at 24 h (anterior and posterior views (b)) showing a moderate and diffuse uptake in the lung parenchima. [¹⁸F]-FDG PET/CT images of the same patient showing a focal/hyleal uptake (coronal and transaxial sections (c)).

(a)

(b)

(c)